Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
clinical trials
3
×
life sciences
national blog main
allergan
biogen
boston
boston top stories
crispr
editas medicine
national top stories
new york blog main
new york top stories
startups
venture capital
abbvie
akouos
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
antisense oligonucleotide
astrazeneca
benzodiazepines
blackstone group
blackstone life sciences
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
columbia university
covid-19
cynthia collins
david goldstein
deals
deerfield management
depression
What
ceo
3
×
medicines
acquisitions
aims
allergan
announced
backed
bio
blessing
bosley
cause
check
clinical
collabs
covid
crispr
cusp
daniel
deal
depart
drugs
editas
editing
epilepsy
experimental
gene
genes
genetic
gilead
gilead’s
help
humans
introduce
ipo
katrine
links
marcio
medicine
million
month
Language
unset
Current search:
biotech
×
ceo
×
" clinical trials "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial